The Mechanisms Underlying PTEN Loss in Human Tumors Suggest Potential Therapeutic Opportunities

Hyeyoun Chang1,2,3, Zhenying Cai1,2, Thomas M Roberts1,2

  • 1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Biomolecules
|November 10, 2019
PubMed

Insights

Loss of the PTEN gene in cancer disrupts cellular pathways, leading to PI3K activation. Understanding these mechanisms offers new therapeutic strategies for PTEN-null tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The phosphatase and tensin homolog (PTEN) tumor suppressor is frequently inactivated in human cancers.
  • Loss of PTEN function disrupts critical signaling pathways, impacting cell growth, survival, and metabolism.
  • Understanding the molecular consequences of PTEN loss is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To review the diverse molecular mechanisms underlying PTEN loss of function in cancer.
  • To elucidate the molecular links between PTEN loss and phosphoinositide 3-kinase (PI3K) pathway activation.
  • To identify potential therapeutic strategies for PTEN-null tumors based on these molecular insights.

Main Methods:

  • Literature review of molecular mechanisms in PTEN-deficient cancers.
  • Analysis of signaling pathways affected by PTEN inactivation.
  • Identification of therapeutic vulnerabilities in PTEN-null tumor models.

Main Results:

  • PTEN loss activates the PI3K/AKT pathway through various mechanisms, including direct and indirect interactions.
  • Dysregulation of downstream effectors of PI3K signaling contributes to tumorigenesis.
  • Specific molecular alterations associated with PTEN loss can be targeted therapeutically.

Conclusions:

  • PTEN loss is a key driver of cancer progression via PI3K pathway activation.
  • Targeting the PI3K pathway and its downstream effectors presents a promising therapeutic avenue for PTEN-null cancers.
  • Further research into PTEN's complex molecular roles will refine treatment strategies.

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K